Molecular Partners AG announced that Pamela A. Trail, Ph.D., will depart from her role as Chief Scientific Officer, effective July 1, 2019. The company's Senior Vice President of Research Daniel Steiner, Ph.D., will assume leadership of the research department of the company. As part of the transition, Dr. Trail will continue to support the company as a strategic consultant.